Integrated Diagnostics Holdings plc

Price Chart

Risk-Adjusted Performance

Also Listed On

Integrated Diagnostics Holdings plc (IDGXF) Price Performance

Integrated Diagnostics Holdings plc (IDGXF) trades on United States in USD. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at $0.64.

Over the past year, IDGXF has traded between a low of $0.31 and a high of $0.70. The stock has gained 106.1% over this period. It is currently 8.3% below its 52-week high.

Integrated Diagnostics Holdings plc has a market capitalization of $462.17M and a dividend yield of 266.00%.

About Integrated Diagnostics Holdings plc

Integrated Diagnostics Holdings plc operates as a consumer healthcare company that provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron emission tomography - computed tomography (PET-CT), MRI, computed tomography (CT), mammography, ultrasound, X-Ray, electromyography, electroencephalography, electroencephalogram, and electrocardiogram, as well as operates cath lab facilities. It operates in Egypt, Sudan, Nigeria, and the Kingdom of Saudi Arabia. The company was founded in 1979 and is based in Saint Helier, Jersey.